Education
2011 - 2017
2011 - 2017Doctorate
Hacettepe University, Eczacılık Fak./ Sağlık Bilimleri Ens./Farmakoloji, Eczacılık/Farmakoloji, Turkey
2006 - 2011
2006 - 2011Undergraduate
Hacettepe University, Eczacılık Fakültesi, Turkey
Dissertations
2017
2017Doctorate
Normaksik ve kronik hipoksik sıçanlarda intermedin’in (IMD/AM2) pulmoner vasküler yatağa etkisinin araştırılması
Hacettepe University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü
Foreign Languages
A2 Elementary
A2 ElementarySpanish
B2 Upper Intermediate
B2 Upper IntermediateEnglish
Certificates, Courses and Trainings
2018
2018Proje Geliştirme Eğitimi
Other
Hacettepe Üniversitesi
2012
2012Deney Hayvanları Kullanım Sertifikası
Vocational Course
Hacettepe Üniversitesi
Research Areas
Health Sciences
Pharmacology and Therapeutics
Professional Sciences
Pharmacology
Academic Positions
2022 - Present
2022 - PresentAssociate Professor
Hacettepe University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü
2013 - Present
2013 - PresentResearch Assistant
Hacettepe University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü
2017 - 2017
2017 - 2017Research Assistant
Ege University, Faculty Of Pharmacy, Eczacılık Meslek Bilimleri Bölümü
Managerial Experience
2024 - Present
2024 - PresentFakülte Öz Değerlendirme Komisyonu Üyesi
Hacettepe University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü
2023 - Present
2023 - PresentAkademik Danışman (Farmasötik Gelişim Topluluğu)
Hacettepe University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü
2023 - Present
2023 - PresentMember of the Faculty Board
Hacettepe University, Eczacılık Fakültesi
2023 - Present
2023 - PresentInternship Committee Member
Hacettepe University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü
Non Academic Experience
2021 - 2022
2021 - 2022Doktora Sonrası Araştırmacı
Madrid Complutense University Faculty of Medicine, Doktora Sonrası Araştırmacı
2011 - 2012
2011 - 2012Eczacı
Monitor Medical Research and Consulting Ltd., Eczacı
Courses
Taught Courses and Trainings
2019 - 2019
2019 - 2019Deney Hayvanları Kullanımı Modül-2 Kursu
Continuing Education Center - Certificate Program
Telli G.
Articles
All (24)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (22)
ESCI (7)
Scopus (19)
TRDizin (8)
2025
20251. Multitarget-directed carbamate and carbamothioate derivatives: Cholinesterase and monoamine oxidase inhibition, anti-(3-amyloid (A(3) aggregation, antioxidant and blood-brain barrier permeation properties against Alzheimer's disease
Tuncel S. T., EROL GÜNAL Ş., Demir I., BAYSAL İ., ERDEM S., TELLİ G., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
, vol.298, 2025 (SCI-Expanded, Scopus)
2025
20252. Synthesis and biological evaluation of novel naproxen-phenacetin triazole hybrids as promising anti-inflammatory agents with enhanced gastrointestinal tolerability
AVCI A., Tasci H., SAĞLIK ÖZKAN B. N., TELLİ G., Gokhan-Kelekci N., ÖZKAY Y., et al.
BIOORGANIC CHEMISTRY
, vol.165, 2025 (SCI-Expanded)
2024
20243. Methylene Blue Attenuates Impaired Cognitive Functions and Reduces Hippocampal Aβ Levels and Oxidative Stress in D-Galactose-Induced Alzheimer’s Disease Mouse Model
Kazkayasi I., TELLİ G.
Biology Bulletin
, 2024 (SCI-Expanded)
2023
20234. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit
Villegas-Esguevillas M., Cho S., Vera-Zambrano A., Kwon J. W., Barreira B., Telli G., et al.
Biomedicine and Pharmacotherapy
, vol.164, 2023 (SCI-Expanded)
2023
20235. Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function
Vera-Zambrano A., Baena-Nuevo M., Rinné S., Villegas-Esguevillas M., Barreira B., TELLİ G., et al.
Pharmacological Research
, vol.189, 2023 (SCI-Expanded)
2022
20226. Allopurinol treatment reduced vascular remodeling and improved vascular functions in monocrotaline-induced pulmonary hypertensive rats
Gokcen T., Inci K., Inci E. E., Sevgen O., Serdar U.
Pulmonary Pharmacology and Therapeutics
, vol.77, 2022 (SCI-Expanded)
2022
20227. Anti-inflammatory effects of oral and intraperitoneal administration of cerium oxide nanoparticles on experimental hepatic ischemia-reperfusion injury
Zengin A., ERİKÇİ A., TELLİ G., GÜMÜŞEL B., KÖSEMEHMETOĞLU K., UÇAR G., et al.
TURKISH JOURNAL OF SURGERY
, vol.38, no.3, pp.255-265, 2022 (ESCI)
2022
20228. Evaluation of Anti-Inflammatory Activity of Metronidazole Treatment On Carrageenan Induced Paw Edema in Mice
Kazkayası Bölük İ., Telli G.
FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , vol.47, no.2, pp.175-182, 2022 (Scopus)
2022
20229. Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease
KAZKAYASI BÖLÜK İ., TELLİ G., NEMUTLU E., Uma S.
LIFE SCIENCES
, vol.299, 2022 (SCI-Expanded)
2022
202210. Scutellaria brevibracteata Stapf and active principles with anti-inflammatory effects through regulation of NF-κB/COX-2/iNOS pathways
DOĞAN Z., TELLİ G., TEL B. C., SARAÇOĞLU İ.
Fitoterapia
, vol.158, 2022 (SCI-Expanded)
2022
202211. Acute hyperglycemia causes oxidative stress which is prevented by vitamin E pretreatment in healthy rabbits
KAZKAYASI İ., TELLİ G., BALCI ÖZYURT A., UMA M. S.
JOURNAL OF RESEARCH IN PHARMACY , 2022 (Peer-Reviewed Journal)
2022
202212. The Role of Metformin and Aerobic Exercise on The Hepatic Ischemia-Reperfusion Injury in Streptozotocin-Induced Diabetic Mice
TELLİ G., Telli-Atalay O.
JOURNAL OF RESEARCH IN PHARMACY
, vol.26, no.3, pp.543-553, 2022 (ESCI)
2022
202213. Acute hyperglycemia causes oxidative stress which is prevented by vitamin E pretreatment in healthy rabbits
Inci K., Gokcen T., Aylin B., Serdar U.
JOURNAL OF RESEARCH IN PHARMACY
, vol.26, no.3, pp.534-542, 2022 (ESCI)
2021
202114. Thyrotropine releasing hormone accelerates wound healing in hyperglycemia inducted mouse fibroblast cell line
DENİZALTI M., Kazkayasi I., TELLİ G.
ISTANBUL JOURNAL OF PHARMACY
, vol.51, no.3, pp.313-318, 2021 (ESCI)
2021
202115. The effects of allopurinol treatment in early period of monocrotaline-induced rat pulmonary hypertension model
TELLİ G., KAZKAYASI İ., Ergonul E. I., Uma S.
BRITISH JOURNAL OF PHARMACOLOGY
, vol.178, no.24, pp.4967-4968, 2021 (SCI-Expanded)
2021
202116. New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors.
Salgin-Goksen U., Telli G., Erikci A., Dedecengiz E., Tel B. C., Kaynak F. B., et al.
Journal of medicinal chemistry
, vol.64, no.4, pp.1989-2009, 2021 (SCI-Expanded, Scopus)
2021
202117. Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A time-course study
TEL B. C., KAZKAYASI İ., TELLİ G., Cinar E., Mutluay S. U., YALÇIN ÇAKMAKLI G., et al.
JOURNAL OF RESEARCH IN PHARMACY
, vol.25, no.3, pp.352-358, 2021 (ESCI)
2021
202118. The effects of 5-hydroxytryptophan on carrageenan-induced mouse paw oedemas
TELLİ G., KAZKAYASI İ., Uma S.
REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
, vol.34, 2021 (SCI-Expanded)
2021
202119. Investigation of the relationship between chronic montelukast treatment, asthma and depression-like behavior in mice
Tel B. C., Telli G., Onder S., Nemutlu E., Bozkurt T. E.
EXPERIMENTAL AND THERAPEUTIC MEDICINE
, vol.21, no.1, 2021 (SCI-Expanded)
2020
202020. The Cardiopulmonary Effects of Calcitonin-Gene Related Peptide Family Kalsitonin-Geni İle İlişkili Peptit Ailesinin Kardiyopulmoner Etkileri
TELLİ G., TEL B. C., GÜMÜŞEL B.
Turkish Journal of Pharmaceutical s
, vol.17, pp.349-356, 2020 (ESCI)
2018
201821. Mechanism of adrenomedullin 2/intermedin mediated vasorelaxation in rat main pulmonary artery
Telli G., Eraç Y., Tel B. C., Gumusel B.
PEPTIDES
, vol.103, pp.65-71, 2018 (SCI-Expanded)
2018
201822. Effect of intermedin/adrenomedullin(2) on the pulmonary vascular bed in hypoxia-induced pulmonary hypertensive rats
Telli G., Tel B. C., Yersal N., Korkusuz P., Gumusel B.
LIFE SCIENCES
, vol.192, pp.62-67, 2018 (SCI-Expanded)
2018
201823. Effects of GPER-1 receptor activation on the reactivity of pulmonary vascular bed and its possible protective role on ischemia/reperfusion
Telli G., Tel B. C., Buyukafsar K., Gumusel B.
JOURNAL OF RESEARCH IN PHARMACY
, vol.22, no.3, pp.422-428, 2018 (ESCI)
2014
201424. EFFECT OF THE G PROTEIN-COUPLED ESTROGEN RECEPTOR-1 (GPER-1) ON THE CONTROL OF PULMONARY ARTERIAL PRESSURE
Telli G., Tel B., Buyukafsar K., Gumusel B.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
, vol.115, pp.21-22, 2014 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2021
20211. The Effects of Allopurinol Treatment in Early Period of Monocrotaline-Induced Rat Pulmonary Hypertension Model
TELLİ G., KAZKAYASI İ., SOMUNCUOĞLU E. İ., UMA M. S.
Pharmacology 2021-British Pharmacological Society, England, 07 September 2021, (Summary Text)
2020
20202. In vitro diyabetik koşullarda protirelinin fibroblast yara iyileşmesine etkisi
KAZKAYASI İ., DENİZALTI M., TELLİ G.
International Eurasian Conference on BioTechnology and BioChemistry, Turkey, 16 December 2020, (Summary Text)
2020
20203. Anti-inflammatory activity of 5-hydroxytryptophan
TELLİ G., KAZKAYASI İ., UMA M. S.
3rd International Eurasion Conference on Biological and Chemical Sciences, Turkey, 19 March 2020, (Summary Text)
2019
20194. Investigation of the relationship between montelukast treatment, asthma and depression-like behavior in mice
TELLİ G., BOZKURT T. E., Onder S., NEMUTLU E., TEL B. C.
European-Respiratory-Society (ERS) International Congress, Madrid, Spain, 28 September - 02 October 2019, vol.54, (Summary Text)
2017
20175. SIÇAN ANA PULMONER ARTERİNDE İNTERMEDİN/ADRENOMEDULLİN2 (IMD/AM2)’NİN HÜCRE İÇİ KALSİYUM KONSANTRASYONUNA ETKİSİNİN İNCELENMESİ
TELLİ G., ERAÇ Y., TEL B. C., GÜMÜŞEL B.
24. Ulusal Farmakoloji Kongresi, Turkey, 17 - 20 October 2017, (Summary Text)
2017
20176. The Role of Potassium Channels in The Relaxation Response of Intermedin/Adrenomedullin2 (IMD/AM2) in The Rat Pulmonary Artery
TELLİ G., TEL B. C., GÜMÜŞEL B.
International Multidisciplinary Symposium on Drug Research and Development, 5 - 07 October 2017, (Summary Text)
2016
20167. Intermedin/Adrenomedullin 2 (IMD/AM2) is a potent vasodilator in chronic hypoxia induced pulmonary hypertensive isolated rat lungs
TELLİ G., Kandilci H. B., TEL B. C., Gumusel B.
Experimental Biology Meeting, California, United States Of America, 2 - 06 April 2016, vol.30, (Summary Text)
2015
20158. Antidepressant activity of novel selective monoamine oxidase A MAO A inhibitors 2 Pyrazoline derivatives synthesized with molecular modelling
TELLİ G., Salgın Gökşen U., ERİKÇİ A., YABANOĞLU ÇİFTÇİ S., TEL B. C., YELEKÇİ K., et al.
International Multidiciplinary Symposium on Drug Research Development 2015, 15 - 17 October 2015, (Summary Text)
2015
20159. Antidepressant activity of novel selective monoamine oxidase A inhibitors 2 Pyrazoline derivatives synthesized with molecular modeling
TELLİ G., salgın gökşen u., ERİKÇİ A., YABANOĞLU ÇİFTÇİ S., TEL B. C., YELEKÇİ K., et al.
International Multidisciplinary Symposium on Drug Research & Development, 15 - 17 October 2015
2015
201510. MAO Inhibitory and Antidepressant Activities of Novel 2 Pyrazoline Derivatives
Salgın Gökşen U., TELLİ G., ERİKÇİ A., YABANOĞLU ÇİFTÇİ S., TEL B. C., UÇAR G., et al.
Pharma Middle East, Dubai, United Arab Emirates, 2 - 04 November 2015, (Summary Text)
2015
201511. Adeno ilişkili viral vektör aracılı Parkinson hastalığı modelinde dentat girusta aşırı alfasinüklein ifadesine bağlı bilişsel fonksiyon değişikliklerinin davranışsal ve histopatolojik değerlendirilmesi
ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., TELLİ G., KAZKAYASI İ., Ulusoy A., et al.
23. Ulusal Farmakoloji Kongresi, Turkey, 7 - 09 September 2015
2015
201512. Does higher alpha-synuclein aggregate density lead to more severe dopaminergic cell loss in the AAV-mediated over-expression model of PD?
ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., TELLİ G., KAZKAYASI İ., ULUSOY A., et al.
19th International of Parkinson’s Disease and Movement Disorders, United States Of America, 14 June 2015, (Summary Text)
2015
201513. Cognitive dysfunction due to over expression of alpha synuclein in hippocampus by using viral vector based approach Modeling cognitive decline in PD
TEL B. C., YALÇIN ÇAKMAKLI G., ÇINAR E., Mutluay S. U., TELLİ G., SAKA TOPÇUOĞLU E., et al.
Movement Disordes Society Meeting 2015, 14 - 18 June 2015
2015
201514. Cognitive dysfunction due to over-expression of alpha-synuclein in hippocampus by using viral vector based approach: Modeling cognitive decline in PD
Tel B., Cakmakli G. Y., Cinar E., Mutluay S. U., Telli G., Saka E., et al.
19th International Congress of Parkinson's Disease and Movement Disorders, California, United States Of America, 14 - 18 June 2015, vol.30, (Summary Text)
2015
201515. Does higher alpha synuclein aggregat density lead to more severe dopaminergic cell loss in AAV mediated over expression model of PD
YALÇIN ÇAKMAKLI G., ÇINAR E., Mutluay S. U., TELLİ G., KAZKAYASI İ., TEL B. C., et al.
Neurizon 2015, 26 - 29 May 2015, (Summary Text)
2014
201416. Effect on G protein coupled estrogen receptor 1 GPER 1 on the control of pulmpnary atrerial presure
Telli G., Tel B. C., Büyükafşar K., Gümüşel B.
17th World Congress of Basic and Clinical Pharmacology, Cape-Town, South Africa, 13 - 18 July 2014, pp.68, (Summary Text)
2014
201417. Hipokampüste AAV-aracılı alfa-sinüklein aşırı ifadesi ile PH modelinde kognitif değişiklikler oluşturulabilir mi?
Yalçın Çakmaklı G., Çınar E., Kazkayası İ., Telli G., Mutluay S. U., Saka Topçuoğlu E., et al.
12. Ulusal Sinirbilim Kongresi, İstanbul, Turkey, 28 - 31 May 2014, vol.77, pp.17, (Summary Text)
Funded Projects
2024 - Present
2024 - PresentAlzheimer Hastalığının Tedavisinde Kullanılmak Üzere Gliburid Iceren Nanosüspansiyon Formülasyonlarının Geliştirilmesi ve Karakterizasyonuna Yönelik Çalışmalar
Project Supported by Higher Education Institutions , BAP Other
GÜLSÜN İNAL T. (Executive), AKDAĞ ÇAYLI Y., ŞAHİN S., TELLİ G., REÇBER T., AYTEKİN E., et al.
2023 - Present
2023 - PresentAlzheimer Hastalığında Kullanılabilecek Yeni Bir Doğal Kaynak Prunella vulgaris L ve Etkin Bileşikleri Tübitak Proje No 121S491Ek Bütçe Desteği
Project Supported by Higher Education Institutions , BAP Other
KUTLUAY V. M. (Executive), DOĞAN Z., PEHLİVAN S., AYTEKİN E., TELLİ G.
2022 - 2025
2022 - 2025Piperasilin tazobaktam ve karbapenem kullanımının karbapeneme dirençli gram negatif bakteriler ile fekal kolonizasyon gelişmesi üzerinde etkisinin karşılaştırılması
Project Supported by Higher Education Institutions , BAP Other
METAN G. (Executive), TELLİ G., HAZIROLAN G., AKOVA M., SARICAOĞLU T., TELLİ DİZMAN G., et al.
2023 - 2024
2023 - 2024Voltajbağımlı potasyum kanalları alt ailesi üyesi 4 KCNE4 geninin sağlıklı ve pulmoner hipertansif dişi ve erkek sıçanların pulmoner düz kas hücrelerindeki düzeylerinin karşılaştırılması
Project Supported by Higher Education Institutions , BAP Research Project
TELLİ G. (Executive)
2023 - 2024
2023 - 2024Dolutegravir ve Doravirinin Sirtuinler Aracılığıyla Yağ Doku Bejleşmesine Etkileri
Project Supported by Higher Education Institutions , BAP Other
İNKAYA A. Ç. (Executive), TELLİ G., UZUN M., ZEYBEK N. D., AYDIN S.
2021 - 2023
2021 - 2023
Streptozotosin ile İndüklenen Diyabet Geliştirilen Farelerde Tirotiropin Salgılattırıcı Hormonun Topikal Uygulamasının Yara İyileşmesine Etkisi
Project Supported by Higher Education Institutions , BAP Other
TELLİ G. (Executive), KAZKAYASI İ., DENİZALTI M., TİMUR S. S.
2020 - 2022
2020 - 2022Monokrotalin İle İndüklenen Sıçan Pulmoner Hipertansiyon Modelinde Allopurinol Tedavisinin Etkisi
Project Supported by Higher Education Institutions , BAP Other
UMA M. S. (Executive), ÖNDER S. Ç., TELLİ G., KAZKAYASI İ., SOMUNCUOĞLU E. İ.
2020 - 2021
2020 - 2021İntraserebroventriküler Streptozotosin Uygulaması ile Alzheimer Hastalığı Oluşturulmuş Farelerde İntranazal Metformin Tedavisi
TUBITAK Project , 1002 - Quick Support Program
KAZKAYASI İ. (Executive), TELLİ G.
2019 - 2020
2019 - 2020
Endemik Scutellaria Rubicunda Hornem. Subsp. Brevibracteata J.R.Edm. Bitkisinin Antienflamatuvar Etkisinin Araştırılması ve Muhtemel Etki Mekanizmasının Açıklanması
TUBITAK Project , 1002 - Quick Support Program
(Project Abstract)
Doğan Z. (Executive), Saraçoğlu İ., Telli G., Tel B. C.
2015 - 2019
2015 - 2019
Bazal gangliyonlarda ve limbik kortekste viral vektör aracılı alfa sinüklein aşırı ifadesine dayalı Parkinson hastalığı modelinde motor ve davranışsal değişikliklerin patoloji ile karşılaştırmalı olarak incelenmesi ve bu modelde rapamisin uygulamasının etkisinin araştırılması
Project Supported by Higher Education Institutions , BAP Research Project
TEL B. C. (Executive), MUTLUAY S. U., ELİBOL B., YABANOĞLU ÇİFTÇİ S., BAYSAL İ., YALÇIN ÇAKMAKLI G., et al.
2016 - 2017
2016 - 2017Sıçan ana pulmoner arterinde intermedinin etki mekanizmasının incelenmesi
Project Supported by Higher Education Institutions , BAP Other
GÜMÜŞEL B. (Executive), TELLİ G., KANDİLCİ H. B., TEL B. C.
2015 - 2016
2015 - 2016Yeni 2-Pirazolin Türevlerinin MAO İnhibitör ve Antidepresan Aktiviteleri
Project Supported by Higher Education Institutions , BAP Other
GÖKHAN KELEKÇİ N. (Executive), UÇAR G., YABANOĞLU ÇİFTÇİ S., TEL B. C., ERİKÇİ A., TELLİ G., et al.
Activities in Scientific Journals
2021 - Present
2021 - PresentFABAD Journal of Pharmaceutical Sciences
Committee Member
Memberships and Roles in Scientific Organizations
2024 - Present
2024 - Present